external-link icon-resource-website icon-resource-website

The work of Alfred Health researchers is published in range of peer reviewed journals.

Search or browse research articles by year, by research area and by publication type.

Publication Details

Overnight counter-regulatory hormone levels and next day glycemia in adults with type 1 diabetes during closed-loop insulin delivery versus sensor-augmented pump with low-glucose suspend

Graf A, Ward GM, Vogrin S, Sundararajan V, Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Roy A, Jones TW, O'Neal DN

(2017), Diabetes Technol Ther, 19(7), 438-9

DOI: 10.1089/dia.2017.0049

"It is definitely a game changer": a qualitative study of experiences with in-home overnight closed-loop technology among adults with type 1 diabetes

Hendrieckx C, Poole LA, Sharifi A, Jayawardene D, Loh MM, Horsburgh JC, Bach LA, Colman PG, Kumareswaran K, Jenkins AJ, MacIsaac RJ, Ward GM, Grosman B, Roy A, O'Neal DN, Speight J

(2017), Diabetes Technol Ther, 19(7), 410-6

DOI: 10.1089/dia.2017.0007

Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6

Liso A, Castellani S, Massenzio F, Trotta R, Pucciarini A, Bigerna B, De Luca P, Zoppoli P, Castiglione F, Palumbo MC, Stracci F, Landriscina M, Specchia G, Bach LA, Conese M, Falini B

(2017), Oncotarget, 8(37), 60826-40

DOI: 10.18632/oncotarget.18338

Poor glycemic control is associated with decreased survival in lung transplant recipients

Hackman KL, Snell GI, Bach LA

(2017), Transplantation, 101(9), 2200-6

DOI: 10.1097/TP.0000000000001555

Thyroid cancer: how to achieve optimal patient outcomes

Qian SY, Topliss DJ

(2017), Med Today, 18(12), 28-35

Evaluation of NovoRapid infusion as a treatment option in the management of diabetic ketoacidosis

Kwok R, Sztal-Mazer S, Hopkins RE, Poole SG, Grannell L, Coutsouvelis J, Topliss DJ

(2017), Intern Med J, 47(11), 1317-20

DOI: 10.1111/imj.13607

Canagliflozin and cardiovascular and renal events in type 2 diabetes

Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group

(2017), N Engl J Med, 377(7), 644-57

DOI: 10.1056/NEJMoa1611925

Pancreatic safety of sitagliptin in the TECOS study

Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group

(2017), Diabetes Care, 40(2), 164-70

DOI: 10.2337/dc15-2780

The management of metastatic radioiodine-refractory differentiated thyroid cancer requires an integrated approach including both directed and systemic therapies

Cooray SD, Topliss DJ

(2017), Endocrinol Diabetes Metab Case Rep, 2017, 16-0089

DOI: 10.1530/EDM-16-0089

Set7 mediated interactions regulate transcriptional networks in embryonic stem cells

Tuano NK, Okabe J, Ziemann M, Cooper ME, El-Osta A

(2016), Nucleic Acids Res, 44(19),

Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study

Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Hendrieckx C, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Speight J, Trawley S, Ward GM, Roy A, Jones TW, O'N

(2016), Diabetes Technol Ther, 18(12),

Current ideas on the biology of IGFBP-6: more than an IGF-II inhibitor?

Bach LA

(2016), Growth Horm IGF Res, 30-31,

Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products

McRobert EA, Bach LA

(2016), Nephrology, 21(1),

Clinical update in aspects of the management of autoimmune thyroid diseases

Topliss DJ

(2016), Endocrinol Metab, 31(4),

Immunoglobulin G4-related thyroid diseases

Kottahachchi D, Topliss DJ

(2016), Eur Thyroid J, 5(4),

Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study

Essig GF Jr, Porter K, Schneider D, Arpaia D, Lindsey SC, Busonero G, Fineberg D, Fruci B, Boelaert K, Smit JW, Meijer JA, Duntas LH, Sharma N, Costante G, Filetti S, Sippel RS, Biondi B, Topliss DJ, Pacini F, Maciel RM, Walz PC, Kloos RT

(2016), Thyroid, 26(11),

Lessons from the bedside: ketoacidosis and SGLT2 inhibitors

Chow YY, Worsley R, Topliss DJ

(2016), Med J Aust, 205(4),

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group

(2016), Diabetes Obes Metab, 18(1),

Hashimoto’s thyroiditis: when to observe, to treat or to refer

Kottahachchi D, Topliss DJ

(2016), Endocrinol Today, 5(2),

Use of anticoagulation in thyroid disease

Polmear JL, Hare MJ, Catford SR, Topliss DJ, Dooley MJ

(2016), Aust Fam Physician, 45(3),